Mark S. Lesney, PhD

News

Polygenic risk score may predict VTE in adolescents, but not adults, with ALL

Author:: Mark S. Lesney, PhD

Publish date: August 14, 2020

A genetic risk score predicted which acute lymphoblastic leukemia–affected adolescents were more at risk of a ven...

News

Elotuzumab-based therapy may benefit post-transplant response in multiple myeloma

Author:: Mark S. Lesney, PhD

Publish date: August 12, 2020

Elotuzumab-based maintenance may deepen response post transplant in MM and can be safely administered in older pa...

News

BALL score predicts benefit from ibrutinib therapy in relapsed/refractory CLL patients

Author:: Mark S. Lesney, PhD

Publish date: August 11, 2020

The BALL score outperformed three other scores in providing the best prediction of an overall survival benefit of...

Opinion

Chronicles of cancer: A history of mammography, part 1

Author:: Mark S. Lesney, PhD

Publish date: August 7, 2020

Tied to the rise of technology and the women's rights movement, the story of mammography is a touchstone for the history of cancer screening and ca...

News

Posaconazole prophylaxis was effective in children with ALL undergoing chemotherapy

Author:: Mark S. Lesney, PhD

Publish date: August 7, 2020

Targeted posaconazole prophylaxis was effective in preventing invasive fungal infection in children with ALL undergoing induction chemotherapy.

News

MM patients with concurrent AL show poor survival when coupled to cardiac dysfunction

Author:: Mark S. Lesney, PhD

Publish date: July 23, 2020

Cardiac dysfunction is a major determinant of poor survival in multiple myeloma patients with concurrent light chain amyloidosis.

News

HSCT or systemic treatment should be offered to HIV+ patients with lymphoma

Author:: Mark S. Lesney, PhD

Publish date: July 16, 2020

Patients with lymphoma and HIV infection benefit from systemic or stem cell therapy, but with worse outcomes than...

News

Heavy menstrual bleeding difficult to control in young patients with inherited platelet disorders

Author:: Mark S. Lesney, PhD

Publish date: July 10, 2020

Consensus and a broadly effective treatment for heavy menstrual bleeding was not found among the patients with inherited platelet function disorder...

News

Transitioning regimen may prolong proteasome inhibitor–based therapy for MM

Author:: Mark S. Lesney, PhD

Publish date: July 9, 2020

Transitioning from parenteral bortezomib-based induction to all-oral ixazomib-lenalidomide-dexamethasone increased PI-based treatment adherence/dur...